INTERNATIONAL STEM CELL CORPORATION
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.1M | $9.1M | $7.8M | $8.2M | $7.2M | $7.1M | $9.5M | $11.1M |
| Cost of Revenue | $4.0M | $3.8M | $3.2M | $3.3M | $2.9M | $2.8M | $3.9M | $4.1M |
| Gross Profit | $5.1M | $5.3M | $4.6M | $4.9M | $4.2M | $4.3M | $5.5M | $7.0M |
| Gross Margin | 55.7% | 58.6% | 59.2% | 60.0% | 59.1% | 61.0% | 58.5% | 63.3% |
| Operating Expenses | ||||||||
| Research & Development | $684.0K | $657.0K | $511.0K | $492.0K | $695.0K | $988.0K | $1.4M | $2.4M |
| SG&A Expense | $3.5M | $3.5M | $3.5M | $3.4M | $4.1M | $4.4M | $7.2M | $5.5M |
| Operating Income | $-267.0K | $-68.0K | $-663.0K | $-183.0K | $-1.9M | $-2.8M | $-5.7M | $-3.5M |
| Operating Margin | -2.9% | -0.7% | -8.5% | -2.2% | -26.8% | -39.5% | -60.5% | -31.3% |
| Interest Expense | $151.0K | $145.0K | $139.0K | $135.0K | $128.0K | $113.0K | $77.0K | $48.0K |
| Pretax Income | $-418.0K | $-209.0K | $-131.0K | $-331.0K | — | — | — | $-2.1M |
| Income Tax Expense | $0 | $0 | — | — | — | — | — | $0 |
| Net Income | $-418.0K | $-209.0K | $-131.0K | $-331.0K | $-899.0K | $-2.7M | $-4.3M | $-2.1M |
| Net Margin | -4.6% | -2.3% | -1.7% | -4.0% | -12.5% | -38.2% | -45.0% | -19.2% |
| EPS (Basic) | $-0.05 | $-0.03 | $-0.02 | $-0.04 | $-0.11 | $-0.36 | $-0.57 | $-0.33 |
| EPS (Diluted) | $-0.05 | $-0.03 | $-0.02 | $-0.04 | $-0.11 | $-0.36 | $-0.57 | $-0.33 |
| Shares Outstanding (Basic) | 8.0M | 8.0M | 8.0M | 8.0M | 7.8M | 7.5M | 7.5M | 6.4M |
| Shares Outstanding (Diluted) | 8.0M | 8.0M | 8.0M | 8.0M | 7.8M | 7.5M | 7.5M | 6.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |